Antibody Responses to BNT162b2 Vaccination in Japan: Monitoring Vaccine Efficacy by Measuring IgG Antibodies against the Receptor-Binding Domain of SARS-CoV-2

To fight severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), mass vaccination has begun in many countries. To investigate the usefulness of a serological assay to predict vaccine efficacy, we analyzed the levels of IgG, IgM, and IgA against...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujigaki, Hidetsugu, Yamamoto, Yasuko, Koseki, Takenao, Banno, Sumi, Ando, Tatsuya, Ito, Hiroyasu, Fujita, Takashi, Naruse, Hiroyuki, Hata, Tadayoshi, Moriyama, Saya, Takahashi, Yoshimasa, Suzuki, Tadaki, Murakami, Takahiro, Yoshida, Yukihiro, Yagura, Yo, Oyamada, Takayoshi, Takemura, Masao, Kondo, Masashi, Iwata, Mitsunaga, Saito, Kuniaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8768797/
https://www.ncbi.nlm.nih.gov/pubmed/35044205
http://dx.doi.org/10.1128/spectrum.01181-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8768797/
https://www.ncbi.nlm.nih.gov/pubmed/35044205
http://dx.doi.org/10.1128/spectrum.01181-21

Ejemplares similares